Document is current
Any future updates will be listed below
-
Authors
Saldanha, Oliver Lester
Goepp, Vivien
Pfeiffer, Kevin
Kim, Hyojin
Zhu, Jie Fu
Kramann, Rafael
Hayat, Sikander
Kather, Jakob Nikolas
-
Funding
Funding for this research was provided by:
Deutsche Kinderkrebsstiftung (70115166)
Deutsche Kinderkrebsstiftung (70115166)
Deutsche Kinderkrebsstiftung (70115166)
Deutsche Kinderkrebsstiftung (70115166)
Bundesministerium für Forschung und Technologie (01KD2104C)
Bundesministerium für Forschung und Technologie (01KD2104C)
Bundesministerium für Forschung und Technologie (01KD2104C)
Bundesministerium für Forschung und Technologie (01KD2104C)
Deutsche Forschungsgemeinschaft (CRU344)
Deutsche Forschungsgemeinschaft (CRU344)
Deutsche Forschungsgemeinschaft (CRU344)
Deutsche Forschungsgemeinschaft (CRU344)
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 4 February 2026
First Online: 18 February 2026
Competing interests
: S.H. is a consultant for Turbine AI, co-founder and shareholder of Sequantrix GmbH, and has received research funding from AskBio and Novo Nordisk. JNK declares consulting services for Bioptimus, France; Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, Synagen GmbH, Germany; has received a research grant by G.S.K.; and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, M.S.D., B.M.S., Roche, Pfizer, and Fresenius. No other competing financial interests are declared by any of the remaining authors.
